CN104771522A - Traditional Chinese medicine for treating pelvic inflammation - Google Patents
Traditional Chinese medicine for treating pelvic inflammation Download PDFInfo
- Publication number
- CN104771522A CN104771522A CN201510164317.3A CN201510164317A CN104771522A CN 104771522 A CN104771522 A CN 104771522A CN 201510164317 A CN201510164317 A CN 201510164317A CN 104771522 A CN104771522 A CN 104771522A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- flos
- inflammatory disease
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Abstract
The invention relates to a traditional Chinese medicine for treating pelvic inflammation. The traditional Chinese medicine consists of the following components in parts by mass: 8-10 parts of rhizoma corydalis, 5-9 parts of honeysuckle, 6-10 parts of white atractylodes rhizome, 4-6 parts of root bark of the peony tree, 4-6 parts of frankincense, 2-6 parts of celosia cristata, 2-4 parts of szechwan Chinaberry fruit, 3-5 parts of caulis spatholobi, 4-8 parts of Chinese mahonia stem, 2-5 parts of dipsacus root, 4-6 parts of carbonized pollen typhae, 2-6 parts of indian lettuce, 2-6 parts of dianthus superbus, 4-6 parts of sophora flower, 5-8 parts of Chinese oak and 3-5 parts of alkanet. The formula can clear away heat and toxic materials, clear away heat and eliminate dampness, activate blood circulation and regulate qi, and strengthen vital qi to eliminate pathogenic factors, and by combining the various medicines, the traditional Chinese medicine has a relatively good effect on treating pelvic inflammation and has a good effect in clinical application; and applied to 130 patients in four years, the medicine can be used for effectively treating pelvic inflammation, with an effective rate of 90.7%.
Description
Technical field
The present invention relates to a kind of Chinese medicine for the treatment of pelvic inflammatory disease, belong to gynecological Chinese medicine formula technique field.
Background technology
Pelvic inflammatory disease and pelvic inflammation, refer to female pelvic cavity genitals, periuterine connective tissue and pelvic peritoneal inflammation.Chronic pelvic inflammation often acute stages treated is not thoroughly delayed, and its disease time is long, and the state of an illness is more obstinate.Antibacterial retrograde infection, by uterus, fallopian tube and arrive pelvic cavity.But in actual life, not all women can suffer from pelvic inflammatory disease, morbidity is minority just.This is because female reproductive system has natural defense function, under normal circumstances, the invasion of antibacterial can be resisted, only have the resistance when body to decline, or due to other reasons the natural defense function of women is destroyed time, just can cause the generation of pelvic inflammatory disease.
Summary of the invention
The object of the present invention is to provide a kind of Chinese medicine for the treatment of pelvic inflammatory disease, to treat for pelvic inflammatory disease better.
To achieve these goals, technical scheme of the present invention is as follows.
Treat a Chinese medicine for pelvic inflammatory disease, be made up of the component of following mass fraction: Rhizoma Corydalis 8 ~ 10 parts, Flos Lonicerae 5 ~ 9 parts, the Rhizoma Atractylodis Macrocephalae 6 ~ 10 parts, Cortex Moutan 4 ~ 6 parts, breast do not have 4 ~ 6 parts, Flos Celosiae Cristatae 2 ~ 6 parts, Fructus Toosendan 2 ~ 4 parts, Caulis Spatholobi 3 ~ 5 parts, Caulis Mahoniae 4 ~ 8 parts, Radix Dipsaci 2 ~ 5 parts, Pollen Typhae carbon 4 ~ 6 parts, Herba Ixeritis Denticulatae 2 ~ 6 parts, Herba Dianthi 2 ~ 6 parts, 4 ~ 6 parts, Flos Sophorae, Cortex Xylosmae japonici 5 ~ 8 parts, Radix Arnebiae (Radix Lithospermi) 3 ~ 5 parts.
Further, the Chinese medicine of above-mentioned treatment pelvic inflammatory disease, is made up of the component of following mass fraction: Rhizoma Corydalis 8 parts, Flos Lonicerae 5 parts, the Rhizoma Atractylodis Macrocephalae 6 parts, Cortex Moutan 4 parts, breast do not have 4 parts, Flos Celosiae Cristatae 2 parts, Fructus Toosendan 2 parts, Caulis Spatholobi 3 parts, Caulis Mahoniae 4 parts, Radix Dipsaci 2 parts, Pollen Typhae carbon 4 parts, Herba Ixeritis Denticulatae 2 parts, Herba Dianthi 2 parts, 4 parts, Flos Sophorae, Cortex Xylosmae japonici 5 parts, Radix Arnebiae (Radix Lithospermi) 3 parts.
Further, the Chinese medicine of above-mentioned treatment pelvic inflammatory disease, is made up of the component of following mass fraction: Rhizoma Corydalis 9 parts, Flos Lonicerae 7 parts, the Rhizoma Atractylodis Macrocephalae 8 parts, Cortex Moutan 5 parts, breast do not have 5 parts, Flos Celosiae Cristatae 4 parts, Fructus Toosendan 3 parts, Caulis Spatholobi 4 parts, Caulis Mahoniae 6 parts, Radix Dipsaci 3 parts, Pollen Typhae carbon 5 parts, Herba Ixeritis Denticulatae 4 parts, Herba Dianthi 4 parts, 5 parts, Flos Sophorae, Cortex Xylosmae japonici 6 parts, Radix Arnebiae (Radix Lithospermi) 4 parts.
Further, the Chinese medicine of above-mentioned treatment pelvic inflammatory disease, is made up of the component of following mass fraction: Rhizoma Corydalis 10 parts, Flos Lonicerae 9 parts, the Rhizoma Atractylodis Macrocephalae 10 parts, Cortex Moutan 6 parts, breast do not have 6 parts, Flos Celosiae Cristatae 6 parts, Fructus Toosendan 4 parts, Caulis Spatholobi 5 parts, Caulis Mahoniae 8 parts, Radix Dipsaci 5 parts, Pollen Typhae carbon 6 parts, Herba Ixeritis Denticulatae 6 parts, Herba Dianthi 6 parts, 6 parts, Flos Sophorae, Cortex Xylosmae japonici 8 parts, Radix Arnebiae (Radix Lithospermi) 5 parts.
Herbal pharmacology and the effect of above-mentioned each component are as follows:
(1) Rhizoma Corydalis: acrid in the mouth, hardship, warm in nature.Return liver, spleen channel.Invigorate blood circulation, dissipating blood stasis, regulates the flow of vital energy, pain relieving.Control all pains of trusted subordinate's waist knee joint, menoxenia, lump in the abdomen, metrorrhagia, puerperal blood faints, lochiorrhea, traumatic injury.
(2) Flos Lonicerae: heat-clearing and toxic substances removing, wind-heat dissipating.For carbuncle furuncle, sore throat, erysipelas, warm blood fulminant dysentery, anemopyretic cold, epidemic febrile disease is generated heat.
(3) Rhizoma Atractylodis Macrocephalae: spleen reinforcing, stomach reinforcing, dampness, and in, antiabortive.Control deficient QI of the spleen and stomach, anorexia, asthenia weak breath, deficiency-distension, has loose bowels, phlegm retention, edema, jaundice, arthralgia chiefly caused by damp pathogen, dysuria, dizzy, spontaneous perspiration, and nausea is uneasy.
(4) Cortex Moutan: bitter in the mouth is pungent, cold nature is nontoxic.Enter the heart, liver, kidney channel.Have and purify the blood, the function of promoting blood circulation to remove blood stasis.Cure mainly macule to spit blood, amenorrhea due to stagnation of blood, premenstrual gesture, carbuncle sore tumefacting virus, traumatic blood stasis, the deficiency of YIN sends out gesture, lossless hectic fever due to YIN-deficiency.
(5) breast does not have: Olibanum energy regulating qi and activating blood, analgesic therapy, chases after poison.Control coagulation of QI-blood, trusted subordinate's pain, carbuncle pyogenic infections from tumour or sore, traumatic injury, dysmenorrhea, postnatal blood stasis twinge.Myrrha cures mainly breast abdomen stasis of blood pain, dysmenorrhea, amenorrhea, lump in the abdomen, traumatic injury, carbuncle skin infection, acute appendicitis, conjunctival congestion and swelling pain.There is the effect such as promoting blood circulation and stopping pain, detumescence and promoting granulation.
(6) Flos Celosiae Cristatae: cool in nature is sweet in the mouth, puckery.Return liver, kidney channel.Astringing to arrest bleeding, leukorrhagia stopping, dysentery relieving.For spitting blood, metrorrhagia, has blood in stool, hemorrhoidal bleeding, leucorrhea with red and white discharge, and chronic dysentery is more than.
(7) Fructus Toosendan: bitter in the mouth, cold in nature.Enter liver, stomach, small intestinal, urinary bladder channel.Soothing liver-QI promoting the circulation of QI to relieve pain, anthelmintic.For the breast side of body, abdominal distention, colic, abdominal pain due to worm stagnation.
(8) Caulis Spatholobi: bitter in the mouth, sweet, warm in nature.Return liver, kidney channel.Enrich blood, invigorate blood circulation, dredging collateral.For menoxenia, blood deficiency and yellow complexion, paralysis and numbness, rheumatic arthralgia.
(9) Caulis Mahoniae: bitter in the mouth, cold in nature.Return large intestine, kidney, lung meridian.Heat clearing away, dampness, removing toxic substances.Main cough due to lung-heat, jaundice, has loose bowels, dysentery, conjunctival congestion and swelling pain, skin infection, eczema, scalds.
(10) Radix Dipsaci: invigorating the liver and kidney, reuniting the fractured tendons and bones, blood circulation regulating.Control aching pain in waist and back, the foot and knee being feeble, vaginal bleeding during pregnancy, metrorrhagia, leukorrhagia, seminal emission, traumatic injury, incised wound, anal fistula, carbuncle skin ulcer swells.
(11) Pollen Typhae carbon: sweet in the mouth, property is put down.Enter liver, heart channel.Hemostasis, blood stasis dispelling, diuresis.Control haematemesis, traumatic hemorrhage, amenorrhea suffer from abdominal pain, puerperal the stasis of blood pain, injury from falling down, blood strangury and dry pain.
(12) Herba Ixeritis Denticulatae: have heat-clearing and toxic substances removing, blood stasis dispelling is invigorated blood circulation, effect of evacuation of pus, cures mainly appendicitis, peritoneal abscess, enteritis, dysentery, acute pelvic inflammatory disease, cough due to lung-heat, pulmonary tuberculosis, haematemesis, epistaxis, traumatic injury, furuncle swells and ache, the disease such as impetigo, eczema scrotum.
(13) Herba Dianthi: bitter in the mouth, cold in nature.Enter the heart, kidney, small intestinal, urinary bladder channel.Clearing away heat and promoting diuresis, removing blood stasis stimulates the menstrual flow.Control urinary obstruction, gonorrhea, edema, amenorrhea, carbuncle, conjunctival congestion is hidden from view, contamination sore.
(14) Flos Sophorae: bitter in the mouth, cold nature.Return liver, large intestine channel.Enter blood to hold back and fall, body slightly falls apart; There is cooling blood for hemostasis, effect of purging liver-fire.Cure mainly discharging fresh blood stool, hemorrhoidal bleeding, dysentery, hematuria, stranguria with blood, metrorrhagia, spit blood, epistaxis, liver-fire is had a headache, conjunctival congestion and swelling pain, sore throat, aphonia, ulcer sores.
(15) Cortex Xylosmae japonici: bitter in the mouth, acid, cool in nature.Enter liver, spleen channel.Dampness, heat extraction.Harness the Yellow River subcutaneous ulcer, scrofula, sore festers.
(16) Radix Arnebiae (Radix Lithospermi): removing heat from blood, invigorates blood circulation, heat clearing away, removing toxic substances.Control warm macule, jaundice due to damp-heat, purpura, tell, be defeated in battle, hematuria, stranguria with turbid discharge, constipation with heat retention, burn, eczema, erysipelas, carbuncle and ulcer.
The mixed infection of pelvic peritoneal inflammation polyphyly, is secondary to the inflammation of pelvic cavity genitals mostly.Pathogen mainly involves pelvic peritoneum with vein or the mode such as lymphsystem diffusion and direct extension, and minority is discharged pus via fimbriated extremity of fallopian and infected.During peritoneal inflammation, first show as hyperemia and edema, and have a small amount of pulp fibers to ooze out, form the adhesion between pelvic cavity viscera, even and around form adhesion between intestinal tube, omentum majus.When there being a large amount of purulence transudates to accumulate in the gap of adhesion, the parcel abscess be dispersed in can be formed.When pus accumulates in douglas cul-de-sac place, and time outstanding to posterior fornix place, then it is uterus rectal sinuses abscess.Its abscess can be broken sometimes into abdominal cavity, causes diffuse peritonitis.When patient's resistance declines, even the threat to life such as septicemia, toxic shock can be caused.
The traditional Chinese medical science is thought, pelvic inflammatory disease is many invades and pelvic cavity, caused by stagnation of QI-blood because of toxic dampness and heat.The origin cause of formation of primary disease, after mainly evil poison invades vessels of the uterus, fights with deteriorated blood and ties, caused by further developing.Due to excess of pathogen, knot in stagnant heat, good and evil are handed over and are striven acutely, and it is heavier to cause stomachache, and have high heat, shiver with cold.When stagnant heat hinders in intestinal, FU QI being obstructed, fecal impaction with watery discharge due to heat accumulation can be caused, and see vomiting, diarrhoea etc.Primary disease take stomachache as main symptom, clinical common real image, thermal image, time dialectical when with the degree of stomachache, with symptom and tongue fur, pulse condition is for foundation, examine card in detail, especially should differentiate mutually with the internal organs excess syndrome of inside and outside section, primary disease, apart from outside heating and stomachache, is often doublely shown in that leukorrhagia is abnormal.Main symptom: lower abdomen has an intense pain, tenderness, companion's abdominal distention, heating.Shiver with cold, nausea and vomiting, even persistent vomiting, constipation with dry stool or diarrhoea, yellow urine, leukorrhagia Huang are thick.Red tongue, dry, rough and yellow fur or yellow thick, wiry and frequent pulse or big vast number.Analyze: excess of pathogen, knot in stagnant heat, good and evil are acutely handed over and are striven, therefore see abdominal pain with tenderness, heating shiver with cold; Stagnant heat hinders in intestinal, FU QI being obstructed, fecal impaction with watery discharge due to heat accumulation, therefore sees abdominal distention, vomiting, constipation with dry stool or diarrhoea; Pyretic toxicity accumulates the long-pending part of the body cavity below the umbilicus, housing the bladder, kidneys and bowels, injures and appoints band, therefore see that leukorrhagia Huang is thick.Tongue arteries and veins is resembling of exuberant evil_heat.
Originally can heat-clearing and toxic substances removing, clearing away heat and eliminating dampness, blood-activating and qi-promoting, righting method is evil, and all medicines coordinate, and have better therapeutic effect to pelvic inflammatory disease, clinical use often receive good effect.In 4 years, by showing the use of 130 patients, this medicine effectively can treat pelvic inflammatory disease, and effective percentage reaches 90.7%.
Below in conjunction with clinical laboratory data, beneficial effect of the present invention is described:
1, physical data: inventor have collected 130 routine Patients with Pelvic Inflammatory Diseases between in March ,-2015 in March, 2011 altogether, wherein, 20 years old ~ 50 years old age, the state of an illness half a year ~ 3 years.Be divided at random: treatment group 65 example, matched group 65 example.The data there was no significant differences such as two groups of ages, have comparability.
2, test method: (1) matched group is taken Flos Lonicerae and secreted scorching clever sheet, takes to specifications.30 days courses for the treatment of.(2) the oral the present invention for the treatment of group is according to the obtained powder of specific embodiment 2, early, middle and late each once.30 days courses for the treatment of.(3) criterion of therapeutical effect and therapeutic outcome: criterion of therapeutical effect: recovery from illness: the clinical symptoms of pelvic inflammatory disease all disappears.Take a turn for the better: the clinical symptom relief of pelvic inflammatory disease, the state of an illness is controlled.Invalid: the clinical symptoms of pelvic inflammatory disease is without being clearly better or increasing the weight of.With recovery from illness and the calculating effective percentage that takes a turn for the better.Treatment statistical result is in table 1.
Table 1 liang group comparitive study
As can be seen here, the medicine adopting prescription of the present invention obtained can safe and effective treatment pelvic inflammatory disease.
Detailed description of the invention
Below in conjunction with embodiment, the specific embodiment of the present invention is described, better to understand the present invention.
embodiment 1
The Chinese medicine of the treatment pelvic inflammatory disease in the present embodiment, take Rhizoma Corydalis 8 grams, Flos Lonicerae 5 grams, the Rhizoma Atractylodis Macrocephalae 6 grams, Cortex Moutan 4 grams, breast do not have 4 grams, Flos Celosiae Cristatae 2 grams, Fructus Toosendan 2 grams, Caulis Spatholobi 3 grams, Caulis Mahoniae 4 grams, Radix Dipsaci 2 grams, Pollen Typhae carbon 4 grams, Herba Ixeritis Denticulatae 2 grams, Herba Dianthi 2 grams, 4 grams, Flos Sophorae, Cortex Xylosmae japonici 5 grams, Radix Arnebiae (Radix Lithospermi) 3 grams.Add 6 times of water gagings, decoct 2 hours, filter; Filtering residue adds 8 times of water gagings, decocts 1 hour, filters; Merging filtrate, concentrated, dry, mix homogeneously, incapsulates shell, must meet the capsule for the treatment of 1 day consumption.Be used for the treatment of pelvic inflammatory disease, oral, every bu is taken for early, middle and late three times.
embodiment 2
The Chinese medicine of the treatment pelvic inflammatory disease in the present embodiment, take Rhizoma Corydalis 9 grams, Flos Lonicerae 7 grams, the Rhizoma Atractylodis Macrocephalae 8 grams, Cortex Moutan 5 grams, breast do not have 5 grams, Flos Celosiae Cristatae 4 grams, Fructus Toosendan 3 grams, Caulis Spatholobi 4 grams, Caulis Mahoniae 6 grams, Radix Dipsaci 3 grams, Pollen Typhae carbon 5 grams, Herba Ixeritis Denticulatae 4 grams, Herba Dianthi 4 grams, 5 grams, Flos Sophorae, Cortex Xylosmae japonici 6 grams, Radix Arnebiae (Radix Lithospermi) 4 grams.Add 10 times of water gagings, decoct 2 hours, filter; Filtering residue adds 8 times of water gagings, decocts 1.5 hours, filters; Merging filtrate, concentrated, dry, close evenly, packaging, the powder for the treatment of 1 day consumption must be met.Be used for the treatment of pelvic inflammatory disease, oral, every bu is taken for early, middle and late three times.
embodiment 3
The Chinese medicine of the treatment pelvic inflammatory disease in the present embodiment, take Rhizoma Corydalis 10 grams, Flos Lonicerae 9 grams, the Rhizoma Atractylodis Macrocephalae 10 grams, Cortex Moutan 6 grams, breast do not have 6 grams, Flos Celosiae Cristatae 6 grams, Fructus Toosendan 4 grams, Caulis Spatholobi 5 grams, Caulis Mahoniae 8 grams, Radix Dipsaci 5 grams, Pollen Typhae carbon 6 grams, Herba Ixeritis Denticulatae 6 grams, Herba Dianthi 6 grams, 6 grams, Flos Sophorae, Cortex Xylosmae japonici 8 grams, Radix Arnebiae (Radix Lithospermi) 5 grams.Add 8 times of water gagings, decoct 1.5 hours, filter; Filtering residue adds 6 times of water gagings, decocts 1 hour, filters; Merging filtrate, concentrated, dry, mix homogeneously, granulates according to this area common process, and packaging must meet the granule for the treatment of 1 day consumption.Be used for the treatment of pelvic inflammatory disease, oral, every bu is taken for early, middle and late three times.
The above is the preferred embodiment of the present invention; it should be pointed out that for those skilled in the art, under the premise without departing from the principles of the invention; can also make some improvements and modifications, these improvements and modifications are also considered as protection scope of the present invention.
Claims (4)
1. treat a Chinese medicine for pelvic inflammatory disease, it is characterized in that: be made up of the component of following mass fraction: Rhizoma Corydalis 8 ~ 10 parts, Flos Lonicerae 5 ~ 9 parts, the Rhizoma Atractylodis Macrocephalae 6 ~ 10 parts, Cortex Moutan 4 ~ 6 parts, breast do not have 4 ~ 6 parts, Flos Celosiae Cristatae 2 ~ 6 parts, Fructus Toosendan 2 ~ 4 parts, Caulis Spatholobi 3 ~ 5 parts, Caulis Mahoniae 4 ~ 8 parts, Radix Dipsaci 2 ~ 5 parts, Pollen Typhae carbon 4 ~ 6 parts, Herba Ixeritis Denticulatae 2 ~ 6 parts, Herba Dianthi 2 ~ 6 parts, 4 ~ 6 parts, Flos Sophorae, Cortex Xylosmae japonici 5 ~ 8 parts, Radix Arnebiae (Radix Lithospermi) 3 ~ 5 parts.
2. the Chinese medicine for the treatment of pelvic inflammatory disease according to claim 1, is characterized in that: described Chinese medicine is made up of the component of following mass fraction: Rhizoma Corydalis 8 parts, Flos Lonicerae 5 parts, the Rhizoma Atractylodis Macrocephalae 6 parts, Cortex Moutan 4 parts, breast do not have 4 parts, Flos Celosiae Cristatae 2 parts, Fructus Toosendan 2 parts, Caulis Spatholobi 3 parts, Caulis Mahoniae 4 parts, Radix Dipsaci 2 parts, Pollen Typhae carbon 4 parts, Herba Ixeritis Denticulatae 2 parts, Herba Dianthi 2 parts, 4 parts, Flos Sophorae, Cortex Xylosmae japonici 5 parts, Radix Arnebiae (Radix Lithospermi) 3 parts.
3. the Chinese medicine for the treatment of pelvic inflammatory disease according to claim 1, it is characterized in that: the Chinese medicine of described treatment pelvic inflammatory disease, is made up of the component of following mass fraction: Rhizoma Corydalis 9 parts, Flos Lonicerae 7 parts, the Rhizoma Atractylodis Macrocephalae 8 parts, Cortex Moutan 5 parts, breast do not have 5 parts, Flos Celosiae Cristatae 4 parts, Fructus Toosendan 3 parts, Caulis Spatholobi 4 parts, Caulis Mahoniae 6 parts, Radix Dipsaci 3 parts, Pollen Typhae carbon 5 parts, Herba Ixeritis Denticulatae 4 parts, Herba Dianthi 4 parts, 5 parts, Flos Sophorae, Cortex Xylosmae japonici 6 parts, Radix Arnebiae (Radix Lithospermi) 4 parts.
4. the Chinese medicine for the treatment of pelvic inflammatory disease according to claim 1, it is characterized in that: the Chinese medicine of described treatment pelvic inflammatory disease, is made up of the component of following mass fraction: Rhizoma Corydalis 10 parts, Flos Lonicerae 9 parts, the Rhizoma Atractylodis Macrocephalae 10 parts, Cortex Moutan 6 parts, breast do not have 6 parts, Flos Celosiae Cristatae 6 parts, Fructus Toosendan 4 parts, Caulis Spatholobi 5 parts, Caulis Mahoniae 8 parts, Radix Dipsaci 5 parts, Pollen Typhae carbon 6 parts, Herba Ixeritis Denticulatae 6 parts, Herba Dianthi 6 parts, 6 parts, Flos Sophorae, Cortex Xylosmae japonici 8 parts, Radix Arnebiae (Radix Lithospermi) 5 parts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510164317.3A CN104771522A (en) | 2015-04-09 | 2015-04-09 | Traditional Chinese medicine for treating pelvic inflammation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510164317.3A CN104771522A (en) | 2015-04-09 | 2015-04-09 | Traditional Chinese medicine for treating pelvic inflammation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104771522A true CN104771522A (en) | 2015-07-15 |
Family
ID=53613505
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510164317.3A Withdrawn CN104771522A (en) | 2015-04-09 | 2015-04-09 | Traditional Chinese medicine for treating pelvic inflammation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104771522A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104958630A (en) * | 2015-07-26 | 2015-10-07 | 孟根森 | Traditional Chinese medicine for treating bowel dysfunction |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020160059A1 (en) * | 2000-09-13 | 2002-10-31 | Wei Xiao | Cinnamomi and poria composition, method to prepare same and uses thereof |
| CN101129868A (en) * | 2007-09-03 | 2008-02-27 | 孙元萍 | Orally taken traditional Chinese medicine composition for treating chronic pelvic inflammatory disease |
| CN104383203A (en) * | 2014-10-17 | 2015-03-04 | 王怀喜 | Traditional Chinese medicine preparation for treating pelvic inflammation |
-
2015
- 2015-04-09 CN CN201510164317.3A patent/CN104771522A/en not_active Withdrawn
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020160059A1 (en) * | 2000-09-13 | 2002-10-31 | Wei Xiao | Cinnamomi and poria composition, method to prepare same and uses thereof |
| CN101129868A (en) * | 2007-09-03 | 2008-02-27 | 孙元萍 | Orally taken traditional Chinese medicine composition for treating chronic pelvic inflammatory disease |
| CN104383203A (en) * | 2014-10-17 | 2015-03-04 | 王怀喜 | Traditional Chinese medicine preparation for treating pelvic inflammation |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104958630A (en) * | 2015-07-26 | 2015-10-07 | 孟根森 | Traditional Chinese medicine for treating bowel dysfunction |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103536888A (en) | Medicine for treating chronic pelvic inflammation and preparation method of same | |
| CN104306944A (en) | Oral medicine for treating varicosities | |
| CN104873851A (en) | Internal and external traditional-Chinese-medicine composition for treating bedsore | |
| CN102580050B (en) | Externally applied traditional Chinese medicine combination for treating chronic pelvic inflammatory disease through applying iontophoresis and preparation method | |
| CN101797332A (en) | Traditional Chinese medicine for treating chronic dacryocystitis and preparation method thereof | |
| CN103007093A (en) | Medicine for treating gynecological inflammation and preparation method thereof | |
| CN104707046A (en) | Traditional Chinese medicine for treating pelvic inflammation | |
| CN104771522A (en) | Traditional Chinese medicine for treating pelvic inflammation | |
| CN103585368B (en) | A kind of Chinese medicine for the treatment of internal hemorrhoid | |
| CN102973744B (en) | Ointment for external use for mixed hemorrhoids care | |
| CN111202833A (en) | Constant-temperature long-acting spontaneous heating plaster for treating osteoarthritis | |
| CN104288558A (en) | Traditional Chinese medicine ointment for treating burns and scalds | |
| CN107496765A (en) | It is a kind of effectively to treat Chinese medicine composition of acute pancreatitis and preparation method thereof | |
| CN103638448B (en) | Medicine used for treating rheumatoid arthritis, and preparation method thereof | |
| CN106310049A (en) | Traditional Chinese medicine granule for treating anorectal diseases and preparation method thereof | |
| CN105412695A (en) | Medicine for treating cow endometritis and preparation method thereof | |
| CN105770209A (en) | Traditional Chinese medicine for treating chronic suppurative parotitis | |
| CN104922409A (en) | Traditional Chinese medicine for treating chronic cervicitis | |
| CN105327299A (en) | Medicine for treating idiopathic thrombocytopenic purpura | |
| CN104436054A (en) | Traditional Chinese medicine for treating rectal cancer | |
| CN104873636A (en) | Hemorrhoid remover and method for preparing pills by utilizing hemorrhoid remover | |
| CN104800685A (en) | Traditional Chinese medicine for treating infection of digestive canal | |
| CN104116839A (en) | Traditional Chinese medicine for treating pelvic inflammation | |
| CN111759913A (en) | Traditional Chinese medicine composition for treating intestinal bleeding and preparation method thereof | |
| CN101822771B (en) | Traditional Chinese medicine composite treating hemorrhoids |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| EXSB | Decision made by sipo to initiate substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20150715 |